|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/397 | (2006.01) |
| A61P 35/00 | (2018.01) | ||
| A61K 9/20 | (2006.01) | ||
| A61P 5/32 | (2018.01) | ||
| A61P 43/00 | (2018.01) | ||
| A61K 9/48 | (2006.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61K 45/06 | (2013.01) | ||
| A61K 31/397 | (2013.01) | ||
| A61K 45/06 | (2006.01) | ||
| A61K 47/10 | (2017.01) | ||
| A61K 47/10 | (2013.01) | ||
| A61K 47/14 | (2017.01) | ||
| A61K 9/0095 | (2013.01) | ||
| A61K 9/00 | (2006.01) | ||
| A61K 9/4866 | (2013.01) | ||
| A61K 47/38 | (2006.01) | ||
| A61K 9/2054 | (2013.01) | ||
| C07D 405/12 | (2006.01) | ||
| A61K 47/14 | (2013.01) | ||
| A61K 9/0014 | (2013.01) | ||
| A61P 15/00 | (2018.01) | ||
| A61K 9/0019 | (2013.01) | ||
| A61K 47/38 | (2013.01) | ||
| C07D 405/12 | (2013.01) |
| (11) | Patento numeris | 3010501 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 14812952.1 |
| Europos patento paraiškos padavimo data | 2014-06-18 | |
| (97) | Europos patento paraiškos paskelbimo data | 2016-04-27 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2021-11-03 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2014/043040 |
| Data | 2014-06-18 |
| (87) | Numeris | WO 2014/205138 |
| Data | 2014-12-24 |
| (30) | Numeris | Data | Šalis |
| 201361836901 P | 2013-06-19 | US | |
| 201461952430 P | 2014-03-13 | US |
| (72) |
KAHRAMAN, Mehmet , US
GOVEK, Steven, P. , US
SMITH, Nicholas, D. , US
HAGER, Jeffrey, H. , US
CHOW MANEVAL, Edna , US
|
| (73) |
Seragon Pharmaceuticals, Inc. ,
12780 El Camino Real, Suite No. 302, San Diego, CA 92130,
US
|
| (54) | ESTROGEN RECEPTOR MODULATOR AND USES THEREOF |
| ESTROGEN RECEPTOR MODULATOR AND USES THEREOF |